According to Emergent BioSolutions, the shelf life for newly manufactured Narcan naloxone nasal spray has been extended to 48 months; the previous shelf life was 36 months. Narcan has been approved for the reversal of opioid overdose in Canada since October 2016.
Emergent Senior VP, Head of Products Business, Paul Williams commented, “Helping to save lives from accidental opioid poisonings is our number one priority and that is why increasing awareness around the potential risks, reducing stigma and improving access to Narcan nasal spray are important efforts as part of the broader solution in Canada. We believe that Emergent’s proactive commitment to extend the shelf-life for Narcan nasal spray offers patients, caregivers and critical community partners the ability to be best prepared to respond to an opioid overdose emergency.”
Read the Emergent Biosolutions press release.
